5月初投的一篇macromolecular rapid communications，今天得知被拒，两个审稿人一个建议接受，一个让转投。感觉还是做得东西创新不够，希望自己能攒攒人品得来好运气。发点金币求个安慰
下面是返回的意见：
Please rate the importance of this submission.
>
> Reviewer #1: Should be published in this journal
> 其他只提了一些语法问题，还是比较温和的
> Reviewer #2: Should be submitted elsewhere
Unfortunately, I am unable to recommend publication of this work in Macromolecular Rapid Commun. In short (i) the there are no new or surprising results at all in the paper and (ii) it is not clear at all what major and important findings the present work adds to the field.
>
> There is really a lot of work ongoing that focuses on the use of some sort of nanomaterial (be it a polymer micelle or something else)that incorporate both a chemotherapeutic and a photosensitizer. A quick search in Web of Science gives close to a 100 papers..... . Yes, the particles in this paper do kill cancers cells, but so do the 99 other papers. What is new, other than maybe the specific type of polymer used ? A new polymer alone (without clearly showing the benefits in a quantitative comparison with the state of the art in the field) is not sufficient reason for publication.
In addition to this, the English is really far way from what one would consider acceptable for a paper in a high impact factor journal.
不知道the state of the art in the field是什么意思，求告解 返回小木虫查看更多